12-66923-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_001170738.2(IQSEC3):āc.41A>Gā(p.Tyr14Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00233 in 1,435,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0024 ( 0 hom., cov: 32)
Exomes š: 0.0023 ( 0 hom. )
Consequence
IQSEC3
NM_001170738.2 missense
NM_001170738.2 missense
Scores
5
6
8
Clinical Significance
Conservation
PhyloP100: 5.12
Genes affected
IQSEC3 (HGNC:29193): (IQ motif and Sec7 domain ArfGEF 3) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in several processes, including actin cytoskeleton organization; activation of GTPase activity; and regulation of small GTPase mediated signal transduction. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.054054618).
BP6
Variant 12-66923-A-G is Benign according to our data. Variant chr12-66923-A-G is described in ClinVar as [Benign]. Clinvar id is 778075.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IQSEC3 | NM_001170738.2 | c.41A>G | p.Tyr14Cys | missense_variant | 1/14 | ENST00000538872.6 | NP_001164209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IQSEC3 | ENST00000538872.6 | c.41A>G | p.Tyr14Cys | missense_variant | 1/14 | 5 | NM_001170738.2 | ENSP00000437554.1 |
Frequencies
GnomAD3 genomes AF: 0.00238 AC: 356AN: 149542Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
356
AN:
149542
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00233 AC: 2990AN: 1285458Hom.: 0 Cov.: 33 AF XY: 0.00259 AC XY: 1636AN XY: 631852
GnomAD4 exome
AF:
AC:
2990
AN:
1285458
Hom.:
Cov.:
33
AF XY:
AC XY:
1636
AN XY:
631852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00238 AC: 356AN: 149652Hom.: 0 Cov.: 32 AF XY: 0.00193 AC XY: 141AN XY: 73116
GnomAD4 genome
AF:
AC:
356
AN:
149652
Hom.:
Cov.:
32
AF XY:
AC XY:
141
AN XY:
73116
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
48
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 22, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Pathogenic
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at